Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/45557
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTraianou, Athina-
dc.contributor.authorUlrich, Martina E. Y.-
dc.contributor.authorApalla, Zoe-
dc.contributor.authorVries, Esther de-
dc.contributor.authorBakirtzi, K.-
dc.contributor.authorKalabalikis, Dimitrios-
dc.contributor.authorFerrándiz, Lara-
dc.contributor.authorRuíz-De-Casas, Andrés-
dc.contributor.authorMoreno-Ramírez, David-
dc.contributor.authorSotiriadis, Dimitrios K.-
dc.contributor.authorIoannides, Demetrios-
dc.contributor.authorAquilina, Susan-
dc.contributor.authorApap, Charmaine-
dc.contributor.authorMicallef, Rita-
dc.contributor.authorScerri, Lawrence-
dc.contributor.authorPitkänen, Sari-
dc.contributor.authorSaksela, Olli-
dc.contributor.authorAltsitsiadis, Efthymios-
dc.contributor.authorHinrichs, Birgit-
dc.contributor.authorMagnoni, Cristina-
dc.contributor.authorFiorentini, Chiara-
dc.contributor.authorMajewski, Slawomir-
dc.contributor.authorRanki, Annamari M.-
dc.contributor.authorProby, Charlotte M.-
dc.contributor.authorStockfleth, Eggert-
dc.contributor.authorTrakatelli, Myrto Georgia-
dc.date.accessioned2019-08-14T09:39:27Z-
dc.date.available2019-08-14T09:39:27Z-
dc.date.issued2012-
dc.identifier.citationTraianou, A., Ulrich, M., Apalla, Z., De Vries, E., Bakirtzi, K., Kalabalikis, D.,...Trakatelli, M. (2012). Risk factors for actinic keratosis in eight European centres: a case–control study. British journal of Dermatology, 167, 36-42.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/45557-
dc.description.abstractSummary - Background: There are limited data regarding the association of actinic keratosis (AK) and other types of nonmelanoma skin cancer (NMSC); studies investigating possible correlation of AK with melanocytic naevi are even scarcer. To our knowledge, there are no data examining the risk of AK in people using specific medications. Objective To investigate constitutional and exposure risk factors leading to AK and the coexistence of AK with NMSC and melanoma. Methods: A multicentre hospital-based case-control study was performed in Finland, Germany, Greece, Italy, Malta, Poland, Scotland and Spain, including 343 patients with actinic keratosis (AK), 409 with squamous cell carcinoma (SCC), 602 with basal cell carcinoma (BCC), 360 with invasive melanoma and 119 with in situ melanoma, and 686 control subjects. Exposures were assessed by questionnaires that were partly self-administered and partly filled out by dermatologists. Unconditional logistic regression modelling was used to assess associations including the influence of phenotypic characteristics, presence of naevi, sun-exposure habits and certain drugs on AK risk. Results: Differences in hair and eye coloration variably influenced the risk for AK, with red hair signifying a seven times higher risk [odds ratio (OR) 6.9, 95% confidence interval (CI) 4.34-11.00), and brown - compared with blue - eyes, about a 40% reduced risk (OR 0.61, 95% CI 0.13-0.92). The darker the skin phototype, the lower the risk for AK, with phototype IV exhibiting nine times less risk of developing AK. Some and many freckles on the arms were associated with an OR of 1.8 (95% CI 1.08-2.81) and 3.0 (95% CI 1.10-3.54), respectively, while overall number of naevi and high educational level were inversely associated with AK. Sun exposure, thiazide diuretics and cardiac drugs had a higher risk for AK. SCC was the most frequent (58%) skin neoplasm coexisting with AKs, followed by BCC (30%), melanoma in situ (12%) and invasive melanoma (6%). Conclusion: In this large case-control study from across Europe the expected associations were confirmed for known risk factors. Some possible new risk factors, including cardiac and diuretic drugs, were identified, creating a new field for further investigation in future studies.en_GB
dc.description.sponsorshipThis publication arises from the EPIDERM project which was funded by the European Commission’s Executive Agency for Health and Consumers (EPIDERM project: PHEA 2007–A ⁄100994 HI). Funding for publication of this supplement was provided by the European Skin Cancer Foundation (ESCF).en_GB
dc.language.isoenen_GB
dc.publisherBJDen_GB
dc.rightsinfo:eu-repo/semantics/restrictedAccessen_GB
dc.subjectKeratosis, Actinic -- Risk factors -- Case studiesen_GB
dc.subjectKeratosis, Actinic -- Case studies -- Europeen_GB
dc.subjectSkin -- Cancer -- Europeen_GB
dc.subjectSkin -- Diseasesen_GB
dc.subjectMelanomaen_GB
dc.titleRisk factors for actinic keratosis in eight European centres : a case–control studyen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.1111/j.1365-2133.2012.11085.x-
dc.publication.titleBritish Journal of Dermatologyen_GB
Appears in Collections:Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
Risk_factors_for_actinic_keratosis_in_eight_European_centres_a_case–control_study_2012.pdf
  Restricted Access
98.95 kBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.